Stabilized Silver Nanoparticle Compositions for Uniform Antimicrobial Coatings
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing silver nanoparticles are either hazardous, expensive, or inefficient, particularly in scaling up manufacturing and applying them to surfaces effectively, as they often require specialized equipment and can lead to cytotoxicity and uneven silver distribution.
Innovation Solution
Development of stabilized silver nanoparticles in a fluid environment, allowing for scalable, non-hazardous production and application to various surfaces, including medical devices, using aqueous or non-aqueous solvents, which can penetrate complex geometries and provide uniform antimicrobial coatings.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If silver metal is deposited as thin films by vacuum sputtering or electroplating, then antimicrobial surface is formed, but surface area is small and silver ion release is limited
Solution Approach 1:
The silver metal is segmented into nanoparticles with sizes ranging from 1 to 100 nanometers. This segmentation dramatically increases the surface area per unit mass, allowing for enhanced silver ion release while maintaining controlled cytotoxicity. The nanoparticles can be dispersed in fluids and applied to surfaces, providing sustained antimicrobial activity without requiring large amounts of silver.
2Reliability
If silver loading is increased to overcome limited ion release, then antimicrobial activity is improved, but cytotoxicity to mammalian cells increases and staining occurs
Solution Approach 1:
The invention changes the physical state of silver from bulk metal or thin films to nanoparticles with controlled size distribution (1-100 nm). This parameter change increases surface area by several orders of magnitude, enabling effective antimicrobial activity at lower silver loadings. The nanoparticle form maintains controlled silver ion release that achieves minimum inhibitory levels against bacteria while staying below cytotoxic thresholds for mammalian cells.
3Area of stationary object
If dry silver nanoparticle processes are used to increase surface area, then silver ion release is improved, but fire hazard increases due to rapid oxidation
Solution Approach 1:
The invention uses liquid vehicles or carriers as intermediaries to deliver silver nanoparticles to surfaces. Instead of handling dry nanoparticle powders that pose fire hazards, the silver nanoparticles are suspended in liquids such as water, alcohols, or other suitable carriers. This liquid delivery system eliminates the fire hazard associated with dry nanoparticle handling while maintaining the high surface area benefits. The liquid vehicle facilitates safe manufacturing, storage, and application processes.
4Quantity of substance
If thermal evaporation under vacuum is used to produce silver particles, then particles are formed, but energy consumption is high and equipment cost is expensive
Solution Approach 1:
The invention replaces thermal evaporation under vacuum with chemical reduction methods in liquid phase. Instead of using high-energy thermal processes and expensive vacuum equipment, the silver nanoparticles are formed by reducing silver salts in liquid solutions using reducing agents. This chemical approach occurs at or near atmospheric pressure, dramatically reducing energy consumption and eliminating the need for specialized vacuum equipment. The process is scalable and suitable for commercial manufacturing.
5Area of stationary object
If silver nanoparticles are produced in dry form, then surface area is increased, but re-dispersion is energy intensive and seldom completely effective
Solution Approach 1:
The invention performs preliminary dispersion of silver nanoparticles in liquid vehicles during the nanoparticle formation process itself. Rather than producing dry nanoparticles that require subsequent re-dispersion, the silver nanoparticles are stabilized in liquid suspensions from the moment of formation. Surfactants or stabilizing agents are used to prevent aggregation and maintain uniform dispersion. This preliminary action eliminates the need for energy-intensive re-dispersion steps and ensures complete, stable dispersion ready for immediate application.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution enables long-term antimicrobial activity on surfaces without cytotoxicity, efficient silver ion release, and scalability, making it suitable for a wide range of medical and non-medical applications while maintaining stability and safety.
Implementation Method 1
Silver derives its broad spectrum antimicrobial activity from the ability of silver ions to bind irreversibly to a variety of nucleophilic groups commonly available in cells of bacteria, viruses, yeast, fungi and protozoa
Implementation Method 2
The compounds or salts upon contact with an aqueous medium ionize to yield silver ions that become available for antimicrobial action
Implementation Method 3
After coming in contact with fluids, silver oxide which is weakly soluble in water, releases therapeutically effective amount of silver ions
Implementation Method 4
The silver nanoparticles allow for very large surfaces per unit mass as surface area per unit volume (or mass) is inversely proportional to its diameter
Implementation Method 5
Air exposure ignites the particles due to very rapid oxidation reactions that are highly exothermic
Data Source
AI summary
The present invention comprises methods and compositions for antimicrobial silver compositions comprising silver nanoparticles. The present invention further comprises compositions for preparing silver nanoparticles comprising at least one stabilizing agent, one or more silver compounds, at least one reducing agent and a solvent. In one aspect, the stabilizing agent comprises a surfactant or a polymer. The polymer may comprise polymers such as polyacrylamides, polyurethanes, and polyamides. In one aspect, the silver compound comprises a salt comprising a silver cation and an anion. The anion may comprise saccharinate derivatives, long chain fatty acids, and alkyl dicarboxylates. The methods of the present invention comprise treating devices with the silver nanoparticle compositions, including, but not limited to, such devices as woven wound care materials, catheters, patient care devices, and collagen matrices. The present invention further comprises treatment of humans and animals wacr6ith the antimicrobial devices described herein.